Mila S. Welling

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Unraveling the relationship between head circumference and MC4R deficiency from infancy to adulthood: a case-control study.

Unraveling the relationship between head circumference and MC4R deficiency from infancy to adulthood: a case-control study.

Journal: Obesity (Silver Spring, Md.)

Published: September 16, 2024

Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway.

Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway.

Journal: Endocrine reviews

Published: April 02, 2024

Treatment with liraglutide or naltrexone-bupropion in patients with genetic obesity: a real-world study.

Treatment with liraglutide or naltrexone-bupropion in patients with genetic obesity: a real-world study.

Journal: EClinicalMedicine

Published: February 06, 2024

MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels.

MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 05, 2023

Clinical phenotypes of adults with monogenic and syndromic genetic obesity.

Clinical phenotypes of adults with monogenic and syndromic genetic obesity.

Journal: Obesity (Silver Spring, Md.)

Published: November 15, 2023

The Narrative of a Patient with Leptin Receptor Deficiency: Personalized Medicine for a Rare Genetic Obesity Disorder.

The Narrative of a Patient with Leptin Receptor Deficiency: Personalized Medicine for a Rare Genetic Obesity Disorder.

Journal: Obesity facts

Published: January 25, 2023

Successful naltrexone-bupropion treatment after several treatment failures in a patient with severe monogenic obesity.

Successful naltrexone-bupropion treatment after several treatment failures in a patient with severe monogenic obesity.

Journal: iScience

Published: November 02, 2022

Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.

Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.

Journal: Frontiers in endocrinology

Published: January 26, 2022

Dextroamphetamine Treatment in Children With Hypothalamic Obesity.

Dextroamphetamine Treatment in Children With Hypothalamic Obesity.

Journal: Frontiers in endocrinology

Published: December 30, 2021

Impact of the COVID-19 Pandemic and Related Lockdown Measures on Lifestyle Behaviors and Well-Being in Children and Adolescents with Severe Obesity.

Impact of the COVID-19 Pandemic and Related Lockdown Measures on Lifestyle Behaviors and Well-Being in Children and Adolescents with Severe Obesity.

Journal: Obesity facts

Published: July 18, 2021

Effects of glucagon-like peptide-1 analogue treatment in genetic obesity: A case series.

Effects of glucagon-like peptide-1 analogue treatment in genetic obesity: A case series.

Journal: Clinical obesity

Published: May 06, 2021

Pharmacotherapy for obesity

Pharmacotherapy for obesity

Journal: Nederlands tijdschrift voor geneeskunde

Published: February 09, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026